Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiaqing Xiong
Observed names:
J. Xiong,
JP Xiong
Institution:
First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Observed institutions:
First Affiliated Hospital of Hunan University of Traditional Chinese Medicine,
First Affiliated Hospital of Nanchang University
ORCID:
0000-0002-2483-9420
Observed ORCID:
0000-0002-2483-9420
OpenAlex ID:
A5018873065
3501 ORAL Capecitabine/cisplatin vs. continuous infusion of 5-FU/cisplatin as first-line therapy in patients (pts) with advanced gastric cancer (AGC): a randomised phase III trial
2007
·
Y. Kang
, W. Kang
, et al.
·
European Journal of Cancer Supplements
·
9
Formononetin, a Key Component of Danggui Buxue Decoction, Inhibits Metastasis of Triple‐Negative Breast Cancer by Modulating SNAI2‐Driven EMT
2025
·
Kui Li
, Ting Zhou
, et al.
·
Food Science & Nutrition
·
3
A phase II study of biweekly gemcitabine at fixed dose rate infusion plus S1 as first-line chemotherapy in patients with locally advanced or metastatic pancreatic cancer.
2016
·
Xj Xiang
, L Zhang
, et al.
·
Journal of Clinical Oncology
·
2
Integrated proteomics and metabolomics reveal NF-κB pathway modulation by Xiangpi Shengji ointment and Qingre Zaoshi compound in anal fistula wound healing
2025
·
Mintao Jian
, Jiaqing Xiong
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
1
Danggui Buxue Decoction Combined with Borneol Improves Cyclophosphamide-Induced Myelosuppression by Inhibiting CDK2
2025
·
Kui Li
, Ruoxia Wu
, et al.
·
Cancer Biotherapy and Radiopharmaceuticals
·
1
Borneol exerts an enhanced anti-tumor effect on triple-negative breast cancer by targeting PTGS2 to reinforce gemcitabine-induced DNA damage
2026
·
Kui Li
, Ruoxia Wu
, et al.
·
Journal of Pharmacy and Pharmacology
Show more works
View as search
Works count:
6
Citation count:
16
H-index:
2
I10-index:
Year
Topic
Type